13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City, China: a case study

13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City, China: a case study

Abstract The World Health Organization (WHO) prioritizes pneumococcal disease as a vaccine-preventable disease and recommends the inclusion of pneumococcal conjugate vaccines (PCV) in national immunization programs worldwide. However, PCV is not included in the National Immunization Program in China...

Full description

Bibliographic Details
Main Authors: Jiachen Wang, Yujue Wang, Ruoyu Xu, Ting Zhang, Yanyan Jiang, Yuanyuan Wang, Yi Wang, Yuanze Du, Wenxue Sun, Kai Deng, Weizhong Yang, Zengwu Wang, Luzhao Feng, Chunping Wang
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Infectious Diseases of Poverty
Subjects:
Pneumococcal conjugate vaccine
Pneumococcal disease
Non-immunization program
Vaccination
Vaccine-preventable disease
Vaccination strategy
Online Access:https://doi.org/10.1186/s40249-023-01165-1

Internet

https://doi.org/10.1186/s40249-023-01165-1

Similar Items